WuXi Biologics (Cayman) Inc. (HKG:2269)
Hong Kong · Delayed Price · Currency is HKD 30.88
-0.50 (-1.59%)
Dec 3, 2025, 2:55 PM HKT
WuXi Biologics Market Cap
WuXi Biologics has a market cap or net worth of 129.21 billion as of December 2, 2025. Its market cap has increased by 83.88% in one year.
Market Cap
129.21B
Enterprise Value
125.58B
Revenue
21.98B
Ranking
n/a
PE Ratio
28.97
Stock Price
30.88
Market Cap Chart
Since June 13, 2017, WuXi Biologics's market cap has increased from 32.04B to 129.21B, an increase of 303.31%. That is a compound annual growth rate of 17.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 130.61B | 81.16% |
| Dec 31, 2024 | 72.10B | -42.32% |
| Dec 29, 2023 | 124.99B | -50.53% |
| Dec 30, 2022 | 252.68B | -35.37% |
| Dec 31, 2021 | 390.94B | -6.90% |
| Dec 31, 2020 | 419.91B | 228.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 293.44B |
| Hansoh Pharmaceutical Group Company | 245.06B |
| JD Health International | 203.29B |
| Innovent Biologics | 162.47B |
| Sino Biopharmaceutical | 123.71B |
| Akeso | 111.09B |
| Sichuan Kelun-Biotech Biopharmaceutical | 102.60B |
| CSPC Pharmaceutical Group | 89.75B |